Dexterra Group (DXT) Q3 2024 earnings summary

Executive summary

• Q3 2024 delivered strong results, with consolidated revenue reaching $269.7 million, up 1.5% year-over-year and 6.4% sequentially, driven by organic growth in WAFES and IFM, and the CMI acquisition.

• Adjusted EBITDA was $32.0 million, down from $38.2 million in Q3 2023 but up from $29.3 million in Q2 2024, reflecting improved IFM margins and strong WAFES occupancy.

• Sale of the Modular Solutions business closed August 30, 2024, simplifying the business model and enabling a focus on core support services and asset-based businesses.

• Profitable organic growth and disciplined acquisitions in IFM are key strategies, with capital return to shareholders through dividends and share buybacks prioritized.

• The company is well positioned for future growth, supported by a strong balance sheet and a supportive major shareholder.

Financial highlights

• Q3 2024 consolidated revenue was $269.7 million, up from $265.8 million in Q2 2024 and $253.6 million in Q3 2023.

• Adjusted EBITDA for Q3 was $32.0 million, down from $38.2 million in Q3 2023 but up from $29.3 million in Q2.

• Free cash flow in Q3 was $11.9 million, an improvement from $10.2 million in Q3 2023.

• Debt at September 30, 2024, was approximately one times Adjusted EBITDA ($102.2 million), down from $139.8 million at Q2, mainly due to proceeds from the modular business sale.

• Adjusted EBITDA margin was 11.9% in Q3 2024, down from 14.4% in Q3 2023.

Outlook and guidance

• IFM Adjusted EBITDA margins are expected to remain above 6% into Q4 2024 and fiscal 2025, supported by labor cost management and acquisitions.

• Annualized organic growth in IFM is projected at 6% for 2024, with a healthy sales pipeline in both Canada and the U.S.

• WAFES Adjusted EBITDA margin is expected to exceed 15% on an annualized basis, supported by high asset utilization and long-term contracts.

• Return on equity targeted at 15% in the near term, with continued focus on profitable growth and market share gains.

• Management intends to continue prudent and conservative balance sheet management.